Mitochondria-mediated production of reactive oxygen species (ROS) plays a key role in apoptosis. Mitochondrial phospholipid cardiolipin molecules are likely the main target of ROS because they are particularly rich in polyunsaturated fatty acids. They are also located in the inner mitochondrial membrane near the ROS-producing sites. Under physiological conditions mitochondria can repair peroxidative damage in part through a remodeling mechanism via the deacylation-reacylation cycle
Mitochondria play a central role in the control of apoptosis (1, 2) . Apoptotic induction triggers the permeabilization of the outer mitochondrial membrane and the release of cytochrome c, which interacts with and causes the oligomerization of monomeric apoptotic protease activating factor-1 (Apaf-1) and the subsequent recruitment of caspase-9 to form the apoptosome (3). Activated caspase-9 then cleaves and activates downstream caspases to amplify the death process (4) .
Mitochondria are also considered to be the most important cellular source of reactive oxygen species (ROS) 2 (5) . Some ROS, such as superoxide (O 2 . ) or hydroxyl radicals (⅐OH), are extremely unstable, whereas others, such as hydrogen peroxide (H 2 O 2 ), are freely diffusible and relatively long-lived. If not adequately neutralized, ROS can damage cells by promoting DNA fragmentation, sulfhydryl-mediated protein cross-linking, and peroxidation of membrane phospholipids. Peroxidation of membrane phospholipids is a major mechanism of ROS attack. Phospholipids, the major building blocks of membranes, are essential for cell life. They are rich in polyunsaturated fatty acids and vulnerable to attack by ROS (6, 7) . It is well known that peroxidation of membrane phospholipids alters membrane fluidity, ion permeability, surface charge, passive electric properties, membranous enzyme activity, and cell signaling (6, 8) . The inner membrane of mitochondria contains a high proportion of the "double" phospholipid cardiolipin, which is particularly rich in unsaturated fatty acids and, thus, particularly susceptible to ROS attack (9) . Indeed, cardiolipin peroxidation in mitochondria has been suggested to play a role in the initiation of the apoptotic signal (10 -12) .
Fortunately, cells can selectively cleave and replace peroxidized fatty acid residues with native fatty acids (8) . Because the polyunsaturated fatty acids in membrane phospholipids tend to be located in the sn-2 position, it is likely that members of the phospholipase A 2 (PLA 2 ) group of enzymes, which share the ability to hydrolyze fatty acids at sn-2 (13, 14) , are involved in this repair activity (7, 8, 15) . Indeed, PLA 2 and acyl-coenzyme A-dependent monolysocardiolipin acyltransferase mediate the rapid remodeling of cardiolipin molecules via the deacylationreacylation cycle in isolated rat liver and heart mitochondria (16 -19) .
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ipate in ongoing membrane phospholipid remodeling and repair via a cycle of deacylation-reacylation (20, 21) . It is also present in rabbit heart mitochondria inner membranes (22) . It is possible that the iPLA 2 -mediated remodeling and repair of membrane phospholipids plays a role in protecting mitochondrial membranes from peroxidative damage.
Staurosporine (STS), a potent protein kinase C inhibitor with a broad spectrum of activity (23) , is known to induce apoptosis through a mitochondria-mediated pathway (24) and to cause oxidative stress through mitochondrially generated ROS in a variety cells (25, 26) . This stress, which can be blocked by Bcl-2 (25) and antioxidants (27) (28) (29) , causes peroxidation of membrane phospholipids, including mitochondrial cardiolipin (12, 26, 28, 30) .
Therefore, STS-induced apoptosis is a useful model for the study of the effects of mitochondrially generated ROS on membrane phospholipid peroxidation. In the present study we use this model to investigate the role of iPLA 2 -mediated phospholipid repair of oxidatively damaged mitochondrial membranes during apoptosis in rat insulinoma INS-1.
EXPERIMENTAL PROCEDURES
Cells and Transfection-Rat insulinoma INS-1 cells or CHO cells were cultured as described previously (31) (32) (33) (34) . Stable expression of iPLA 2 in an INS-1 cell line (iPLA 2 -INS) was previously established using the retroviral vector pMSCVneo (Clontech, Palo Alto, CA) containing iPLA 2 cDNA downstream of a 5Ј long terminal repeat from the PCMV virus as described (31, 35, 36) . For expression of iPLA 2 , we used the expression vector pcDNA3-iPLA 2 to transfect the cells with a FuGENE 6 transfection reagent (Roche Applied Science) as described (34) . For expression of iPLA 2 -GFP fusion protein, the expression vector pEGFP-N2-iPLA 2 was constructed by subcloning fulllength rat iPLA 2 cDNA in-frame upstream of the GFP cassette in the pEGFP-N2 vector (Clontech). Transfected cells stably expressing iPLA 2 -GFP were selected with G418 (active concentration, 400 g/ml).
Detection of Apoptosis-Apoptosis was induced by treating the cells with STS (Sigma), actinomycin D, etoposide, camptothecin (CHEMICON International, Inc.), or H 2 O 2 (Promega). Multiple methods were used to detect apoptosis. For detection of phosphatidylserine (PS) externalization by flow cytometry, an annexin V-FLUOS staining kit (Roche Applied Science) was used to stain cells with fluorescent isothiocyanate-conjugated annexin V and propidium iodide (PI) according to the manufacturer's protocol. Briefly, ϳ10 6 cells were harvested, washed with PBS by centrifugation at 200 ϫ g for 5 min, and resuspended in 100 l of annexin V-FLUOS labeling solution containing annexin V and PI. Cells were incubated for 10 -15 min at 15-25°C and immediately analyzed by flow cytometry on a BD Biosciences FACSCalibur (34) . PS externalization is a unique marker for apoptosis. Combined staining with annexin V and PI can be used to determine the early and late apoptosis. Cells were considered early apoptotic when they were annexin V-positive and PI-negative and late-apoptotic when they were both annexin V-and PI-positive. For detection of DNA fragmentation, fragmentized DNA was purified using the apoptotic DNA ladder kit (Roche Applied Science) and analyzed by electrophoresis in 1% agarose gel with ethidium bromide staining.
Measurement of Caspase Activity-For determination of caspase 3 activity, cells were pretreated with or without 20 M Z-DEVD-FMK (BD Biosciences), a caspase 3 specific inhibitor, or 20 M Z-IETD-FMK (BD Biosciences), a caspase 8 specific inhibitor, and followed by apoptotic induction. Then the cells were counted with hemacytometer. 10 6 cells were resuspended in cell lysis buffer (Promega, Madison, WI) and analyzed with the CaspACE Assay System Colorimetric (Promega) according to the manufacturer's protocol.
Western Blot Analysis-The cytosol and mitochondrial fractions of cells were obtained with mitochondria/cytosol fractionation kit following the manufacturer's protocol (BioVIsion, Mountain View, CA). The protein concentration of the supernatant was determined by Bradford assay using bovine serum albumin as the standard. Aliquots (containing 60 g for cytoplasmic fraction or 15 g for mitochondrial fraction) were separated by SDS-PAGE, transferred to nitrocellulose, blotted with corresponding antibodies, and detected by ECL WESTERN blotting detection system (Amersham Biosciences). AntiiPLA 2 , anti-cPLA 2 , anti-cytochrome c, anti-Smac/DIABLO, anti-AIF, anti-actin antibodies (Santa Cruz), and anti-histone H4 (Upstate, Waltham, MA) antibodies were used.
Confocal Microscopy-Confocal fluorescence microscopy was performed using a Zeiss LSM 510 META confocal laser scanning microscope (Carl Zeiss MicroImaging, Inc. Thornwood, NY). INS-1 cells were transfected with pEGFP-N2-iPLA 2 construct and grown on cover slides. After induction of apoptosis, the cells were incubated in 50 nM MitoTracker Red CMXRos (Molecular Probes) for 15 min, washed with PBS, fixed in 3.8% paraformaldehyde (Fisher), and stained with 300 nM 4Ј,6-diamidino-2-phenylindole (Molecular Probes). The samples were embedded in Vectashield Mounting Medium H-1000 (Vector Laboratories, Burlingame, CA) and analyzed on a Zeiss LSM 510 META confocal laser-scanning microscope.
Measurement of Mitochondrial Membrane Potential-Mitochondrial membrane potentials were determined by the JC-1 (5,5Ј,6,6Ј-tetrachloro-1,1Ј,3,3Ј-tetraethylbenzimidazolylcarbocyanine) mitochondrial membrane potential detection kit according to the manufacturer's protocol (Cell Technology, Mountain View, CA). Briefly, after induction of apoptosis, cells were washed with PBS and labeled with the JC-1 reagent for 15 min. After washing, the mitochondrial membrane potential was measured on a BD Biosciences FACSCalibur flow cytometer. Mitochondria containing red JC-1 aggregates in healthy cells were detectable in the FL2 channel, and green JC-1 monomers in apoptotic cells were detectable in the fluorescein isothiocyanate channel. The loss of mitochondrial membrane potential was calculated as the percentage of green cells versus total cells.
Measurement of Mitochondrial Generation of ROS-Intramitochondrial generation of superoxide (O 2 . ) was determined by the superoxide-induced conversion of the superoxide-sensitive dye, dihydroethidium (HE) to the highly fluorescent ethidium (37, 38 Measurement of Lipid Peroxidation-The Oxltek TBARS assay kit (ZeptoMetrix) was used to assess lipid peroxidation according to the manufacturer's protocol. Briefly, samples of cell suspension were separated into aliquots, and 2.5 ml of trichloroacetic acid/TBARS reagent was added. Each sample was incubated at 95°C for 60 min. Supernatants were analyzed by a spectrophotometer at 532 nm, and values were expressed as a percentage of values in controls.
iPLA 2 Activity Assay-iPLA 2 activity was determined using a modified kit originally designed for cytosolic Ca 2ϩ -dependent PLA 2 (cPLA 2 ) (cPLA 2 assay kit, Cayman Chemicals) as described (33, 39) . Briefly, after specific treatments, cultured cells were collected and homogenized in buffer (50 mM Hepes, pH 7.4, and 1 mM EDTA) followed by centrifugation at 14,000 ϫ g for 20 min at 4°C. The supernatant was removed, and the protein concentration was determined. iPLA 2 activity was assayed by incubating the samples with arachidonoyl thio-PC for 1 h at 25°C in Ca 2ϩ -free buffer (4 mM EGTA, 160 mM Hepes, pH 7.4, 300 mM NaCl, 8 mM Triton X-100, 60% glycerol, and 2 mg/ml bovine serum albumin). The reaction was stopped by the addition of 5,5Ј-dithiobis(nitrobenzoic acid) for 5 min, and absorbance was determined at 414 nm using a Quant microplate reader (BIO-TEK Instruments, Inc., Winooski, VT). The specific activity of iPLA 2 was calculated and expressed in nmol/min/mg of total proteins. The background basal lipase activity, which was determined by inhibiting all specific iPLA 2 activity in control samples with bromo- enol lactone (BEL), was subtracted from all readings as described (33, 39) .
Isolation of RNA and RT-PCR Analysis-Total RNA was isolated from INS-1 cells using the RNeasy Mini Kit (Qiagen, Valencia, CA). RT-PCRs were performed using the Qiagen OneStep RT-PCR Kit (Qiagen), and the RT-PCR products were analyzed by electrophoresis in a 1% agarose gel with ethidium bromide staining. Primers for amplification of a fragment (505 bp) of rat iPLA 2 were sense (5Ј-ATGCAGTTCTTTGGACGC-3Ј) and antisense (5Ј-CCAGAATCTCACTGTCAC-3Ј) and for amplification of rat glyceraldehyde-3-phosphate dehydrogenase were sense (5Ј-TGTCAGCAATGCATCCTG-3Ј) and antisense (5Ј-AACACGGAAGGCCATGCC-3Ј).
Statistical Analysis-Data were expressed as the mean Ϯ S.D. The statistical significance of differences was analyzed using Student's t test, where p Ͻ 0.05 was considered significant.
RESULTS

iPLA 2 Protects Cells from Mitochondrial Stress-induced
Apoptosis-STS has previously been shown to induce apoptosis (24), mitochondrial superoxide (O 2 . ) generation (25), and membrane phospholipid peroxidation (26, 28, 30) . To verify these findings in rat insulinoma INS-1 cells, we treated INS-1 cells with 1 M STS and analyzed for apoptosis by flow cytometry after staining with annexin V-FLUOS (Fig. 1A) . We also used HE staining to assess mitochondrial superoxide generation (Fig. 1B ) and the TBARS assay to measure lipid peroxidation levels ( To investigate the role of iPLA 2 in apoptosis induced by mitochondrially generated ROS, we compared the effect of STS on INS-1 cells with its effect on INS-1 cells stably expressing iPLA 2 (iPLA 2 -INS) (31, 35) . We first rigorously analyzed the time course of STS-induced apoptosis in each cell line using annexin V labeling followed by flow cytometric analysis. As shown in Fig. 2 , iPLA 2 -INS cells were relatively resistant to STS-induced apoptosis compared with parental INS-1 cells. We found that the peak of early apoptosis (annexin V-positive and PI-negative) occurred between 8 to 12 h in both cell lines, and many of these cells progressed into late apoptosis (annexin V-and PI-positive) ( Fig. 2A) . However, in contrast to the INS-1 cells, which were nearly all dead 36 h after STS treatment, about 40% of iPLA 2 -INS cells remained alive (Fig. 2B) , and many cells were still in early apoptosis after the same amount of time ( Fig. 2A) . These results clearly show that although STS induces a considerable amount of cell death in iPLA 2 -INS cells, their apoptotic progression is significantly delayed in comparison to INS-1 cells.
To evaluate whether the degree of apoptotic resistance correlates with the level of iPLA 2 expression, we first analyzed the effect of iPLA 2 on apoptosis in a population of cells. INS-1 cells were transfected with iPLA 2 -GFP, and apoptosis was induced with STS. After PI staining, cells were sorted via FACS using two gates, one for PI and one for GFP. After sorting, cells were divided into groups according to their levels of GFP expression (inset in Fig. 2C) , and the extent of cell death within each group (PI-positive cells) was determined. As shown in Fig. 2C , groups with no or low levels of GFP expression exhibited the highest proportions of dead cells. As iPLA 2 -GFP fusion protein expression increased, the proportion of PI-positive cells in each group fell. These results suggest that resistance to STS-induced apoptosis is positively correlated with higher iPLA 2 levels. To confirm this finding, we selected and expanded individual colonies expressing variable levels of iPLA 2 . Once again, as shown in Fig.  2D , as iPLA 2 expression increased, the proportion of dead cells decreased.
To determine the extent of resistance of iPLA 2 -INS cells to apoptotic induction by STS, we treated both cell lines with increasing concentrations of STS for 8 h. As shown in Fig. 2E , when STS concentration was increased to 5 M, we saw no significant difference in cell death levels between INS-1 cells and those expressing iPLA 2 , indicating that the stronger apoptotic induction overcame the protective function of iPLA 2 .
To confirm that iPLA 2 -INS cells were relatively resistant to STS-induced apoptosis, we also looked for the appearance of DNA ladders. DNA fragmentation was apparent in INS-1 within 4 h of STS treatment and intensified with time. However, DNA fragmentation was significantly attenuated in iPLA 2 -INS cells (Fig. 3A) .
We also compared STS-induced caspase-3 activation between the two cell lines (Fig. 3B) . A difference in the degree of caspase 3 activation could be detected within 2 h of STS treatment and became significant after 4 h. Although the activity increased prominently in a time-dependent manner in INS-1 cells, there was no significant increase in iPLA 2 -INS cells after 4 h, indicating that elevated levels of iPLA 2 prevent the activation of caspase 3 in STS-induced apoptosis.
It has been reported that STS causes the release of histones into the cytoplasm during apoptosis (40) . As shown in 3C, this release of histones from nucleosomes to cytoplasm was very prominent in INS-1 cells; they were evident on the Coomassie Blue-stained SDS-PAGE and reacted strongly with anti-histone H4 antibodies on the Western blot (Fig.  3C) . Furthermore, the timing of histone release correlated well with the progression of apoptosis in the INS-1 cells. In contrast, many fewer histones were released in the iPLA 2 -INS cells in response to STS treatment. Taken together, our results unambiguously demonstrate that iPLA 2 protects ␤-cells from apoptosis induced by mitochondrial stress.
To determine whether iPLA 2 can also protect other types of cells from apoptosis, we transfected CHO cells with a pDNA3-iPLA 2 construct. As a control, a separate group of CHO cells were mock-transfected. Both groups of cells were then treated with 1 M STS. Similar to our results in INS-cells, DNA fragmentation in iPLA 2 -expressing CHO cells was also dramatically less than that seen in the control cells (Fig. 3C) .
We next examined the effects of actinomycin D and etoposide, which are known to induce the mitochondrial production of ROS (41, 42) . As shown in Fig. 3E , apoptosis induced by these reagents was significantly less pronounced in overexpressing iPLA 2 (16 -19) . Because STS induces apoptosis through a mitochondria-mediated pathway (25) and because iPLA 2 -expressing cells were resistant to STS induction (Figs. 2 and 3 ), we hypothesized that iPLA 2 mediates the deacylation of mitochondrial cardiolipin (16 -19) . Therefore, we investigated whether iPLA 2 is associated with cellular mitochondria. INS-1 cells were transfected with a pEGFP-iPLA 2 construct, incubated with MitoTracker Red CMXRos, and counterstained with 4Ј,6-diamidino-2-phenylindole before analysis with a laser scanning confocal microscope. Yellow staining of the mitochondria, resulting from the merging of the green and red signals, clearly indicates the co-localization of iPLA 2 with mitochondria (Fig. 4A) , consistent with a previous report indicating that iPLA 2 was present in the inner membranes of rabbit heart mitochondria (22) .
About 50% of cells in this experiment, corresponding closely to the transfection efficiency of the pEGFP-iPLA 2 construct, expressed GFP-iPLA 2. Most of their mitochondria were associated with iPLA 2 in the absence of STS (see Control in Fig. 4B ). Four hours after STS treatment, the ratio of the transfected (green) and non-transfected cells (red staining only) had not significantly changed. However, after 8 -12 h of STS treatment, the proportion of green cells far exceeded the proportion of red cells (Fig. 4B) , indicating most surviving cells expressed GFPiPLA 2 . In addition, slightly more yellow dots were observed in the surviving cells, suggesting that further translocation of iPLA 2 may have occurred during STS treatment.
We also carefully examined individual cells during STS-induced apoptosis. Most mitochondria were associated with iPLA 2 after an induction time of 8 h or less (Fig. 4C) . A proportion of cells expressing GFP-iPLA 2 underwent apoptosis, visualized by the alteration of chromatin, after 12 h of induction. Most of the mitochondria in these cells were not associated with iPLA 2 (12 h, Fig. 4C ). Our results demonstrate that iPLA 2 localizes to mitochondria and protects them during apoptotic induction by STS.
Expression of iPLA 2 in INS-1 Cells Prevents the Loss of Mitochondrial Membrane
Potential-Alteration of mitochondrial membrane potential is an important early transition in the induction of apoptosis. During this process the electrochemical gradient across the mitochondrial membrane collapses. To determine whether iPLA 2 can prevent the loss of mitochondrial membrane potential, we treated both INS-1 and iPLA 2 -INS cells simultaneously with STS for various lengths of time and measured the mitochondrial membrane potential with flow cytometry (Fig. 5, A and B) . We detected a significant loss of mitochondrial membrane potential in INS-1 cells within 2 h after STS treatment, and membrane potential continued to decline as long as the STS treatment continued (Fig. 5B) . However, no significant loss of mitochondrial membrane potential was detected in iPLA 2 -INS cells until 8 h after STS treatment. Similar results were observed when iPLA 2 was overexpressed in CHO cells (Fig. 5C ). These results demonstrate that iPLA 2 prevents the loss of mitochondrial membrane potential during STS treatment.
We further tested whether iPLA 2 also prevents the loss of mitochondrial membrane potential induced by exogenously added H 2 O 2 . We treated both cell lines with increasing concentrations of H 2 O 2 for 4 h and then measured mitochondrial membrane potentials as before. As shown in Fig. 5D , 100 M In addition to cytochrome c, other mitochondrial proteins such as Smac/DIABLO, which promotes cytochrome cdependent caspase activation by eliminating IAP inhibition (43) , and apoptosis inducing factor (AIF), which induces chromatin condensation and large scale DNA fragmentation (44) , are also released during apoptosis. We found that iPLA 2 expression also attenuates the STS-induced release of these two factors (Fig. 6B) .
iPLA 2 2 can protect mitochondrial function from ROS inducers or H 2 O 2 treatment, we examined whether it affects the amount of ROS generated by mitochondria in response to STS. Interestingly, we found that iPLA 2 -INS cells had much lower levels of ROS production than did parental INS-1 cells after 8 h of STS treatment (Fig. 7) . However, ROS production dropped sharply in INS-1 cells after 12 h (Fig. 7) when more than 75% of INS-1 cells were dying and losing mitochondrial membrane potential (Figs. 2 and Fig. 5B) . Although it is possible that the mitochondria of the INS-1 cells completely fail at this time and are unable to produce any more ROS, our data suggest that iPLA 2 protects mitochondrial function, reducing ROS production and delaying mitochondrial damage during apoptosis.
-INS Cells Produce Lower Levels of ROS than Do Parental INS-1 Cells in Response to STS Treatment-Because iPLA
Using a TBARS assay, we observed no significant reduction of total lipid peroxidation in iPLA 2 -INS cells compared with INS-1 cells after STS treatment. It has been demonstrated that STS induces the oxidation of two relatively minor anionic phospholipids, cardiolipin and PS, but not more abundant phospholipids like phosphatidylcholine and phosphatidylethanolamine (12, 45) . The TBARS assay is not sensitive enough to detect differences in lipid peroxidation between the two cell lines.
Caspase 8 Activation Is Not Required for STS-induced Apoptosis of INS-1 Cells-Stimulation
with some chemotherapeutic drugs leads to caspase 8 activation, which may serve as either an initiating or as a secondary event in apoptosis (46, 47) . Activated caspase 8 either directly activates the executioner caspase, caspase 3 (48), or cleaves the BH3-only protein Bid to generate tBid (49) . Activation of caspase 3 may also activate caspase 8 in an apoptotic feedback loop (50 -52) . To examine whether caspase 8 activation plays a role in STS-induced apoptosis in INS-1 cells, we treated the cells with both camptothecin, which induces apoptosis through activation of caspase 8 (53) , and STS in the presence or absence of the caspase 8-specific inhibitor Z-IETD-FMK (52). We found that although camptothecin induced dramatic levels of cell death within 4 h in untreated cells, its effect was essentially blocked when the cells were pretreated with Z-IETD-FMK (Fig. 8A) . However, STSinduced apoptosis in INS-1 cells was not affected by treatment with Z-IETD-FMK (Fig. 8A) .
We further analyzed caspase 3 activation in the presence and absence of inhibitors specific for caspase 3 (Z-DEVD-FMK) or 8 (Z-IETD-FMK). We found that although the caspase 8-specific inhibitor completely inhibited camptothecin-induced caspase 3 activation, it did not affect STS-induced caspase 3 activation (Fig. 8B) . These results indicate that, consistent with previous reports (46, 54) , the mitochondrial amplification loop driven by caspases 3 and 8 is not required for STS-induced apoptosis.
cPLA 2 Does Not Participate in STS-induced Apoptosis of INS-1 Cells-It has been reported that group IV cPLA 2 participates in apoptosis induced by tumor necrosis factor and the divalent cation ionophore A23187 (55, 56) . To evaluate whether cPLA 2 activation is involved in STS-induced apoptosis in INS-1 cells, we pretreated INS-1 cells with the cPLA 2 -specific inhibitors methyl arachidonyl fluorophosphonate or arachidonyl trifluoromethyl ketone before STS treatment. Then cells were collected and analyzed for apoptosis with annexin V staining and flow cytometry. We found that neither arachidonyl fluorophosphonate (Fig. 9A ) nor arachidonyl trifluoromethyl ketone (data not shown) affected STS-induced apoptosis. In contrast, pretreatment of INS-1 cells with the iPLA 2 -specific inhibitor BEL enhanced STS-induced apoptosis over time (Fig. 9B) . We also did not detect any notable changes in either cell line in protein levels, post-translational modification (Fig. 9C) , cPLA 2 activity, or arachidonic acid release before or after STS treatment. Therefore, we conclude that neither cPLA 2 nor arachidonic acid participate in STS-induced apoptosis.
iPLA 2 Is Transcriptionally Down-regulated in STS-induced Apoptosis-Because iPLA 2 plays an important role in the protection of mitochondria during STS-induced apoptosis, we examined whether STS treatment affects iPLA 2 expression in ␤-cells. INS-1 and iPLA 2 -INS cells were treated with STS for varying lengths of time, and lysates from both cells were analyzed for the presence of iPLA 2 by Western blot. Interestingly, iPLA 2 protein levels decreased in a time-dependent manner in INS-1 cells and were hardly detectible after 8 h of STS treatment (Fig. 10A) . In contrast, iPLA 2 levels in iPLA 2 -INS cells decreased during the first 4 h of STS treatment but remained constant for the remainder of the experiment. Because the expression of recombinant iPLA 2 in iPLA 2 -INS cells is driven by a promoter derived from the murine stem cell PCMV virus, this result suggests that STS down-regulates the transcription of endogenous iPLA 2 . In addition, we did not detect any truncated iPLA 2 bands during STS treatment even though the antibody we used (T-14, Santa Cruz) recognizes the C terminus of iPLA 2 . Finally, we found that iPLA 2 activity coincided with its protein levels (Fig. 10B) .
To confirm that STS down-regulates iPLA 2 transcription, we used RT-PCR to quantify iPLA 2 mRNA levels after STS treatment. As shown in Fig. 10C , although endogenous iPLA 2 mRNA in INS-1 cells disappeared with time, iPLA 2 mRNA in the iPLA 2 -INS cells decreased during the first 4 h but remained constant for the remainder of the experiment. Our results suggest that STS not only induces oxidative stress leading to the peroxidation of mitochondrial membrane phospholipids but also impairs the repair system by down-regulating iPLA 2 transcription.
DISCUSSION
It has been hypothesized that oxygen free radicals cause impaired membrane function primarily by peroxidizing membrane lipid components. The mitochondrial phospholipid cardiolipin has long been regarded as a target of this attack due to its particularly high polyunsaturated fatty acid content and its location in the inner mitochondrial membrane near the ROSproducing sites.
To keep mitochondrial membranes in optimal condition, cells must replace peroxidized residues with native fatty acids (8) . It has been proposed that the consecutive action of PLA 2 and phospholipid glutathione peroxidase are required to reduce phospholipid hydroperoxides in mitochondria under physiological conditions (57) . iPLA 2 participates in ongoing membrane phospholipid remodeling via a cycle of deacylation and reacylation (20, 21) . Although it is logical that iPLA 2 may also play an important role in repairing peroxidized phospholipids, little is known about its biological significance in protecting mitochondrial membranes from this type of damage. In this study, we used STS to induce mitochondrial ROS production in rat insulinoma INS-1 cells. We demonstrated for the first time that iPLA 2 can prevent mitochondrially generated ROS-induced apoptosis, as evidenced by decreased PS externalization, caspase-3 activity, DNA fragmentation, and histone release from nucleosomes.
Mitochondrial cardiolipin is distinguished from other phospholipids by an abundance of linoleoyl molecular species (58) . In fact, 70% of the fatty acids in mitochondrial cardiolipin in rat islets are linoleic acid (59) . It is likely that linoleate enrichment occurs as a result of cardiolipin remodeling, since cardiolipin synthesis shows no preference for the various molecular species of CDP-diacylglycerol (58 (16) . Monolysocardiolipin acyltransferase, which mediates reacylation by lioleoyl-coenzyme A, exhibits a preference for unsaturated acyl-coenzyme A substrates (17) .
Although PLA 2 activity has been characterized in mitochondria, it's not known which specific subfamily is involved in cardiolipin remodeling. Our data indicating that iPLA 2 co-localizes with mitochondria, together with a previous report that iPLA 2 is present in rabbit heart mitochondrial inner membranes (22) , suggest that iPLA 2 plays a key role in the mediation of cardiolipin deacylation and the repair of mitochondrial membranes. iPLA 2 expression in INS-1 cells prevents the loss of mitochondrial membrane potential and attenuates the release of cytochrome c, Smac/DIABLO, and AIF from mitochondria to cytosol. Furthermore, this protection of mitochondria by iPLA 2 results in a feedback loop that reduces mitochondrial ROS production.
The release of cytochrome c from mitochondria is a central event in the induction of apoptosis (60) . This release appears to be initiated by cardiolipin oxidation (12, 61) . Recent findings indicate that cytochrome c extrusion occurs as a two-step process; dissociation of cytochrome c from cardiolipin on the inner mitochondrial membrane (62) , induced by the peroxidation of cardiolipin by mitochondrially generated ROS (63, 64) , and release of the solubilized pool of cytochrome c after permeabilization of the outer mitochondrial membrane, regulated mainly by the Bcl-2 family (2). Neither disrupting the interaction of cytochrome c with cardiolipin nor permeabilizing the outer membrane with Bax alone is sufficient to trigger this proteins release (62) . Our data show that expression of iPLA 2 in INS-1 cells prevents the loss of mitochondrial membrane potential more significantly than cytochrome c release into the cytosol. This suggests that iPLA 2 -mediated phospholipid remodeling and repair help cells eliminate peroxidized fatty acids from mitochondrial inner membranes, which may prevent the dissociation of cytochrome c from cardiolipin but not the release of solubilized pool of cytochrome c into the extra mitochondrial environment through mitochondrial outer membrane permeabilization (2) . The fact that iPLA 2 localizes to mitochondria before STS treatment indicates that mitigating the peroxidative damage of mitochondrial inner membranes is an intrinsic physiological function of iPLA 2 .
It is somewhat surprising that STS down-regulates iPLA 2 transcription because iPLA 2 has been thought of as a housekeeping protein that is not subject to transcriptional regulation. Our results reveal for the first time that STS induces apoptosis at least in part by down-regulation of iPLA 2 . This down-regulation results in the loss of cardiolipin remodeling and repair of phospholipid peroxidation and leads to mitochondrial failure and cell death. This sequence of events is consistent with our observation by confocal microscopy that most iPLA 2 -transfected INS-1 cells, but not untransfected cells, survive STS treatment.
iPLA 2 contains several caspase 3 consensus sites, and cleavage at these sites permanently activates iPLA 2 (14, (65) (66) (67) (68) . This caspase 3-dependent activation of iPLA 2 reportedly amplifies apoptosis induced by Fas and thapsigargin (65) (66) (67) . Cardiac ischemia, well known to activate caspase 3 (69), also reportedly activates iPLA 2 (22, 70) . Finally, it has been reported that long term exposure of cells to high levels of H 2 O 2 (500 M) activates iPLA 2 and accelerates apoptosis (71) .
Because caspase 3 activation marks cells for death, the permanent activation of iPLA 2 by caspase 3 may facilitate the characteristic biologic and morphologic changes of apoptosis. Indeed, iPLA 2 has been shown to mediate the release of the chemoattractant lysophosphatidylcholine to recruit monocytic cells and primary macrophages to engulf the apoptotic cell and prevent the release of toxic cellular contents (68) . Accumulated evidence suggests that iPLA 2 plays a dual role in cells; its intrinsic function is to prevent apoptosis by remodeling mitochondrial cardiolipin and repairing peroxidative damage to mitochondrial membranes caused by mitochondrially generated ROS. However, once cell death is made inevitable by the activation of caspase 3, iPLA 2 as well as other caspase 3-activated proteins such as the deoxyribonuclease/DNA fragmentation factor (CAD/DFF40) (72) actively facilitate apoptotic progression and the rapid removal of apoptotic cells (73) .
In summary, our study demonstrates that iPLA 2 localizes in mitochondria and is likely involved in mitochondrial membrane remodeling and repair under physiological conditions. Down-regulation of iPLA 2 by STS may result in failure to repair peroxidative damage of membrane phospholipids, particularly those in the mitochondria. This leads to the subsequent loss of mitochondrial membrane potential, the release of cytochrome c and other apoptotic proteins, and apoptosis. Expression of iPLA 2 ex vivo may, therefore, prevent mitochondrial failure and apoptosis.
